I expect many of you have already seen reports that the European Advocate General has taken a very restrictive view on patents for technologies that use human embyronic stem cells. This is the next installment in a long-running legal battle over a patent awarded to stem cell scientist Oliver Bruestle in 1999 and challenged by Greenpeace in 2004. Prof Bruestle and others are voicing serious concerns about the Advocate General’s postion (see news story at
http://www.eurostemcell.org/story/european-advocate-general-critical-stem-cell-patents for example). Just wondered what Node readers think about all this?
GD Star Rating
loading…
Rate comment: